Imeka Solutions Inc.
Entry updated on July 4, 2023
Who are we?
details
Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss.
Products and services
details
Imeka’s ANIE (Advanced Neuro Imaging Endpoints) biomarker platform combines white matter imaging with artificial intelligence to analyze white matter MRI signals in greater detail than anyone else.
Expertises
AI Capacities
details
Who are we?
Mission
Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma and biotech clients in the development of treatments for neurodegenerative diseases.
Vision
Imeka’s main goal is to play an influential role in the search and development of cures for brain disease.
Products and services
Description
We offer medical image processing services and develop software associated with these services.
Why do business with us?
We are the only company to combine artificial intelligence and diffusion MRI to help our biopharmaceutical clients accelerate their drug development research. We helped Inmune Bio show the efficacy of their Alzheimer’s drug in Phase Ib to raise an additional $40 million to launch Phase II, which will start soon.
AI Capacities
Organization size
10 to 49 employees
AI Organization size
4 employees